IL‐33 is related to innate immune activation and sensitization to HDM in mild steroid‐free asthma

IL‐33 represents a potential link between the airway epithelium and induction of a Th2‐type inflammatory response in asthma. However, the association with markers of eosinophilic airway inflammation has not previously been reported in patients with steroid‐free asthma.

[1]  C. Porsbjerg,et al.  Airway responsiveness to mannitol in asthma is associated with chymase‐positive mast cells and eosinophilic airway inflammation , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  A. Bush,et al.  Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33 , 2015, The Journal of allergy and clinical immunology.

[3]  Richard J Martin,et al.  Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. , 2015, The Journal of allergy and clinical immunology.

[4]  G. Criner,et al.  Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. , 2015, Immunity.

[5]  C. Brightling,et al.  IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk , 2015, Allergy.

[6]  C. Buchrieser,et al.  Corrigendum: Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline , 2015, Nature Communications.

[7]  N. Papadopoulos,et al.  IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. , 2014, American journal of respiratory and critical care medicine.

[8]  H. Hammad,et al.  Allergens and the airway epithelium response: gateway to allergic sensitization. , 2014, The Journal of allergy and clinical immunology.

[9]  W. Henderson,et al.  Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33. , 2014, The Journal of allergy and clinical immunology.

[10]  J. Virchow,et al.  IL‐33 is a mediator rather than a trigger of the acute allergic response in humans , 2014, Allergy.

[11]  Ruksha Bhadresha.  Dupilumab in persistent asthma with elevated eosinophil levels , 2013, Thorax.

[12]  A. Bush,et al.  IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. , 2013, The Journal of allergy and clinical immunology.

[13]  W. Thomas,et al.  Innate affairs of allergens , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  M. C. R. Medeiros,et al.  Toll‐like receptors 2, 3 and 4 and thymic stromal lymphopoietin expression in fatal asthma , 2012, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[15]  Ian D Pavord,et al.  Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial , 2012, The Lancet.

[16]  K. Ishii,et al.  A critical role of IL-33 in experimental allergic rhinitis. , 2012, The Journal of allergy and clinical immunology.

[17]  S. Holgate.  Innate and adaptive immune responses in asthma , 2012, Nature Medicine.

[18]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[19]  Shing-Hwa Liu,et al.  Mite Allergen Der-p2 Triggers Human B Lymphocyte Activation and Toll-Like Receptor-4 Induction , 2011, PloS one.

[20]  Margaret W Leigh,et al.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.

[21]  L. Wood,et al.  Characterization of innate immune signalling receptors in virus‐induced acute asthma , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  A. Bergqvist,et al.  Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma. , 2011, The Journal of allergy and clinical immunology.

[23]  B. Medoff,et al.  Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. , 2011, American journal of respiratory cell and molecular biology.

[24]  C. Lloyd.  IL-33 family members and asthma - bridging innate and adaptive immune responses. , 2010, Current opinion in immunology.

[25]  Q. Hamid,et al.  Increased IL-33 expression by epithelial cells in bronchial asthma. , 2010, The Journal of allergy and clinical immunology.

[26]  R. Flavell,et al.  Caspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages1 , 2009, The Journal of Immunology.

[27]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[28]  M. Conforti,et al.  The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis , 2009, Annals of the rheumatic diseases.

[29]  Mingcai Li,et al.  Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. , 2009, Biochemical and biophysical research communications.

[30]  H. Hammad,et al.  House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells , 2009, Nature Medicine.

[31]  D. Postma,et al.  Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction , 2009, Nature Genetics.

[32]  Jens Nielsen,et al.  Systems Analysis Unfolds the Relationship between the Phosphoketolase Pathway and Growth in Aspergillus nidulans , 2008, PloS one.

[33]  J. Girard,et al.  The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.

[34]  S. Wenzel,et al.  IL‐13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  M. Hayakawa,et al.  Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation* , 2007, Journal of Biological Chemistry.

[36]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[37]  Klas Svensson,et al.  Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.

[38]  E. Raz,et al.  Cutting Edge: Activation of Toll-Like Receptor 2 Induces a Th2 Immune Response and Promotes Experimental Asthma1 , 2004, The Journal of Immunology.

[39]  S. Anderson,et al.  A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. , 1997, American journal of respiratory and critical care medicine.

[40]  A. Woolcock,et al.  Rapid method for measurement of bronchial responsiveness. , 1983, Thorax.

[41]  E. Bleecker,et al.  Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma. , 2015, The Journal of allergy and clinical immunology.

[42]  S. Willsie.  Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma , 2010 .